Mestastop and Immunobiome started their collaboration in October 2020. Precisely fifteen months down the line, they filed the provisional specification for their first patent; “Method for producing a spontaneous metastasis model”. The patent describes a way to create an orthotopic …
Two years back, when the wet lab got operational, we wanted to create a benchtop platform for cancer metastasis that would encompass all the complexity but be simple to execute. Our goal was to understand the differential functional properties of …
Biotechnology startup Mestastop Solutions raised Rs 1.3 crore in a seed funding round, led by CIIE.CO. The round also saw participation from IKP Knowledge Park and Angels. Mestastop will use the funding to scale its AI-based platform METSCAN, which characterizes cancer cells using patient …
Mestastop Solutions have signed a memorandum of understanding with Syngene to provide its proprietary platform for metastasis discovery on a non-exclusive basis to Syngene clients, as per certain terms and conditions. Mestastop, a start-up biotech that specializes in the understanding …
Mestastop Solutions, the deep-tech biotechnology startup working on cancer metastasis has entered a collaboration with Peptris, an AI / ML company that can predict protein-protein interaction and identify small molecule inhibitors. Together they will identify, validate, and develop approved drugs …
Mestastop Solutions have appointed Ankesh Khemani, as an Advisor for “Data Strategy and AI”. Ankesh brings in his diverse experience and expertise and will be advising Mestastop on their machine learning algorithm platform that will be integrating the vast data generated …
Mestastop Solutions have raised a third successive round of funding against Compulsorily Convertible Preference Shares (CCPS) that was led by Vistari Venture Partners and other angel investors, two of whom are in a leadership role in Indian Biotech (name withheld …
Mestastop Solutions have partnered with Science Exchange, the globally recognized and respected online marketplace by major biopharmas, to offer their proprietary functional assay platform on metastasis. “We’re pleased to welcome Mestastop Solutions as a Science Exchange Contracted™ provider on our …
Mestastop, a two-year-old cancer metastasis focused biotech start up based at Bangalore, India that have raised money from Mumbai Angels and owner of Curadev Pharma, have officially announced a collaboration with the South Korea based ImmunoBiome Inc, to develop novel …
Mestastop is a Bangalore based biotech startup that is stopping the unstoppable ‘cancer metastasis’ and giving life a second chance. Metastasis is the movement of tumor cells through blood and formation of multiple tumors into different secondary sites of the …